Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Barry K. Herman, M.D. who wrote (529)	4/1/1998 10:02:00 PM
From: LemonHead	Read Replies (1) of 1491

Bausch&Lomb BOL Morgan Stanley¯ Outperform Been thinking about this, and would like some comments as to on base or off? Without details, I remember that there was a meeting with some analyst the day of FDA approval. I think that we all were told that some of the major firms were in attendance (but I don't recall seeing a list of those present). General consensus being that major firm could not recommend until $5 or better. Is it possible this is how they get the ball rolling by starting with the Partner? Accumulation and profit on both. I think this approval is extremely positive. Any devils advocates? Keith

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next